Castleview Partners »

Reviva Pharmaceu shares owned by Castleview Partners

Quarter-by-quarter ownership of Reviva Pharmaceu (RVPH) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Reviva Pharmaceu

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceu held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceu by Castleview Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 16k 0.73

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Advisor Managed Portfolios Regan Fixed Rate (MBSX)
ConocoPhillips (COP)
Apple (AAPL)
Tesla Motors (TSLA)
Managed Portfolio Series Leuthold Select (LST)
Bristol Myers Squibb (BMY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Home Depot (HD)
Kkr & Co (KKR)
Vaneck Etf Trust Real Assets Etf (RAAX)
Fidelity Covington Trust High Divid Etf (FDVV)
Amgen (AMGN)
UnitedHealth (UNH)

View all positions for Castleview Partners

Top funds holding Reviva Pharmaceu

Millennium Management
Jpmorgan Chase & Co
Armistice Capital
GSA Capital Partners
EMC Capital Management
Vanguard Capital Management
Warberg Asset Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Hrt Financial
Castleview Partners
Two Sigma Investments
Morgan Stanley
UBS Group

View all funds holding Reviva Pharmaceu